Work

Final Results of a Phase 1B of Omp-59R5 (Anti-Notch2/3/Stem Cell Antibody) in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + Gem) in Patients (Pts) with Untreated Metastatic Pancreatic Cancer (Mpc): Alpine Study

Year: 2014

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu334.73

Authors: J. Bendell, A.L. Cohn, L. Smith, J.H. Strickler, W.L. Gluck, W.G. Schmidt, A. Kapoun, L. Xu, D. Hill, L. Zhou, J. Dupont, E.M. O'Reilly

Institutions: Sarah Cannon, Tennessee Oncology, Rocky Mountain Cancer Centers, South Texas Accelerated Research Therapeutics, Duke University, Duke Medical Center, Prisma Health, OncoMed (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2309812512

FWCI: 0.161

Cites:

Cited by: 2

Related to: 10